Here's what happened to the stock market on Thursday

Questions over remdesivir

The Financial Times said — citing documents accidentally published by the World Health Organization — that Gilead Sciences' drug remdesivir did not improve patients' condition or reduce the coronavirus pathogen in their bloodstream. Those findings, according to the report, came from a clinical trial in China. Gilead took exception with the report, saying: "it was underpowered to enable statistically meaningful conclusions.

レムデシビルに関する質問 フィナンシャルタイムズ紙は、世界保健機関が誤って発行した文書を引用して、ギリアドサイエンスの薬物レムデシビルが患者の状態を改善したり、血流中のコロナウイルス病原体を減らしたりしなかったと述べました。レポートによると、これらの

Financial times manipulated the market with a report from the corrupt ,dishonest and now defunded WHO. On a study , now get this , done in China. The country that made and released the cirus ,then lied about it. Causing thousands of deaths. THAT is who they choose to believe?

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

These 5 low-key tech stocks with appealing dividend yields are profiting from coronavirus-induced uncertaintyOPINION: Consider these low-key tech stocks because they have appealing dividend yields and are profiting from the coronavirus-induced uncertainty.
Source: MarketWatch - 🏆 3. / 97 Read more »

Market strategist says these 3 indicators will signal when it's time to buy stocks - Business InsiderMarket strategist Tony Dwyer says he will turn bullish on stocks when he sees these signs in credit markets. Indicators tell you late and are created to give people false hope. If you could actually use indicators to make consistent profit and then everyone would do it and everyone would be profitable wouldn’t they? Just their to give people false sense of security. In November, obviously.
Source: BusinessInsider - 🏆 729. / 51 Read more »